Download
fcell-09-698639.pdf 3,30MB
WeightNameValue
1000 Titel
  • Extracellular Vesicles From the Human Natural Killer Cell Line NK3.3 Have Broad and Potent Anti-Tumor Activity
1000 Autor/in
  1. Cochran, Allyson M. |
  2. Kornbluth, Jacki |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-23
1000 Erschienen in
1000 Quellenangabe
  • 9:698639
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-25
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fcell.2021.698639 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343581/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>Natural killer (NK) cells are critical mediators of immune function, responsible for rapid destruction of tumor cells. They kill primarily through the release of granules containing potent cytolytic molecules. NK cells also release these molecules within membrane-bound exosomes and microvesicles – collectively known as extracellular vesicles (EV). Here we report the characterization and anti-tumor function of EVs isolated from NK3.3 cells, a well described clonal normal human NK cell line. We show that NK3.3 EVs contain the cytolytic molecules perforin, granzymes A and B, and granulysin, and an array of common EV proteins. We previously reported that the E3 ubiquitin ligase, natural killer lytic-associated molecule (NKLAM), is localized to NK granules and is essential for maximal NK killing; here we show it is present in the membrane of NK3.3 EVs. NK3.3-derived EVs also carry multiple RNA species, including miRNAs associated with anti-tumor activity. We demonstrate that NK3.3 EVs inhibit proliferation and induce caspase-mediated apoptosis and cell death of an array of both hematopoietic and non-hematopoietic tumor cell lines. This effect is tumor cell specific; normal cells are unaffected by EV treatment. By virtue of their derivation from a healthy donor and ability to be expanded to large numbers, NK3.3 EVs have the potential to be an effective, safe, and universal immunotherapeutic agent.</jats:p>
1000 Sacherschließung
lokal exosome
lokal leukemia
lokal breast cancer
lokal natural killer
lokal NKLAM
lokal Cell and Developmental Biology
lokal NK3.3
lokal extracellular vesicle
lokal ubiquitin ligase
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Q29jaHJhbiwgQWxseXNvbiBNLg==|https://frl.publisso.de/adhoc/uri/S29ybmJsdXRoLCBKYWNraQ==
1000 Hinweis
  • DeepGreen-ID: 457349f8f4ea40debbcbd5ced1a20a85 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. U.S. Department of Veterans Affairs |
  2. National Center for Advancing Translational Sciences |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer U.S. Department of Veterans Affairs |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer National Center for Advancing Translational Sciences |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6477273.rdf
1000 Erstellt am 2024-05-17T12:16:30.403+0200
1000 Erstellt von 322
1000 beschreibt frl:6477273
1000 Zuletzt bearbeitet 2024-05-17T14:47:35.944+0200
1000 Objekt bearb. Fri May 17 14:47:35 CEST 2024
1000 Vgl. frl:6477273
1000 Oai Id
  1. oai:frl.publisso.de:frl:6477273 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source